BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/9/2026 5:32:37 AM | Browse: 3 | Download: 0
| Category |
Biology |
| Manuscript Type |
Opinion Review |
| Article Title |
Compound danshen dripping pills for non-proliferative diabetic retinopathy: Efficacy, mechanisms, and future directions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jin-Wei Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82170406 and No. 81970238 |
|
| Corresponding Author |
Jin-Wei Zhang, PhD, Principal Investigator, Professor, State Key Laboratory of Chemical Biology, Research Center of Chemical Kinomics, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, No. 345 Lingling Road, Shanghai 200032, China. jinweizhang@sioc.ac.cn |
| Key Words |
Compound danshen dripping pills; Non-proliferative diabetic retinopathy; Diabetic retinopathy; Traditional Chinese medicine; Efficacy; Mechanisms |
| Core Tip |
Non-proliferative diabetic retinopathy, a common type 2 diabetes complication, has Western therapies limited by cost, side effects, and incomplete control. Compound danshen dripping pills, a patented traditional Chinese medicine, improves retinal health (reducing microaneurysms, edema) alone or with Western drugs via multi-targeted pathways, with mild side effects. Research gaps exist; future studies should address these to integrate compound danshen dripping pills into global guidelines. |
| Citation |
Zhang JW. Compound danshen dripping pills for non-proliferative diabetic retinopathy: Efficacy, mechanisms, and future directions. World J Diabetes 2026; In press |
 |
Received |
|
2026-01-12 01:24 |
 |
Peer-Review Started |
|
2026-01-13 07:27 |
 |
First Decision by Editorial Office Director |
|
2026-02-04 09:47 |
 |
Return for Revision |
|
2026-02-04 09:47 |
 |
Revised |
|
2026-02-08 08:58 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-09 02:32 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-09 05:32 |
 |
Articles in Press |
|
2026-04-09 05:32 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345